Amedisys Inc (NASDAQ:AMED) Has Just Had Its Target Price Upgraded by Research Analysts at RBC Capital Markets to $41.00
Stock Analysis:Amedisys Inc (NASDAQ:AMED) Price Target Upgraded In analysts note announced by RBC Capital Markets on Friday, 27 November, Amedisys Inc (NASDAQ:AMED) had its TP…
